Abstract
Background
The relationship between metabolic syndrome (MetS) and hyperuricemia is not fully understood.
Objective
To examine the association of hyperuricemia with MetS and the component of MetS that is mostly influenced by hyperuricemia among university workers.
Methods
Anthropometric measurements, blood pressure, glucose, lipid profiles, renal function tests were measured in 1198 male and 1075 female (22–60 years old) workers on annual medical examination.
Results
Hyperuricemia was 3-fold higher in males (odds ratio, OR, 2.938, 95% confidence interval, CI, 1.909–4.522, P<0.01) than females after adjustment for age, body mass index (BMI) and renal function. Overall, individuals with hyperuricemia were 3.9-fold likely to have MetS OR, 3.903; CI (2.439–6.245), P<0.01, and dyslipidemia, 2.5 times (OR, 2.501; 95% CI, 1.776–3.521, P<0.01) after adjustment for age, BMI, sex and renal function. However, no associations were found in individuals with hypertension (OR, 1.427; 95% CI, 0.996–2.205, P=0.052) and hyperglycemia (OR, 1.476; 95% CI, 0.989–2.202, P=0.057). Administrative work positively associated (OR, 1.895; 95% CI, 1.202–2.925, P<0.05) with hyperuricemia in males and not females.
Conclusion
Male workers with hyperuricemia, especially those working in administration were at risk of metabolic syndrome. It is important to screen, prevent and treat metabolic syndrome in individuals diagnosed with hyperuricemia at the workplace.
Keywords: Hyperuricemia, metabolic syndrome, uric acid, workers
Introduction
Metabolic syndrome (MetS) is a known risk factor for many chronic diseases including cardiovascular diseases (CVD), type 2 diabetes mellitus, chronic kidney diseases (CKD), among others1. The increasing prevalence of MetS in many vulnerable populations poses a serious public health problem worldwide. The prevention of MetS and its individual components among high-risk populations has been identified as an important intervention strategy for reduction of chronic diseases and the associated health costs2. Thus, the crucial basis for developing and implementing workplace-specific health interventions requires the identification of major MetS risk factors and their distribution patterns among workers in different occupations3.
Current interventions towards reduction of cardio-metabolic risks in the workplace target diet and physical activity as certain occupations promote unhealthy dietary patterns. Among the modulators of MetS, recent studies4,5 focused on hyperuricemia, the elevated concentrations of uric acid (UA) in the blood. UA, the final product of purine metabolism is a very important diagnostic and prognostic factor in many disorders. The plasma level of UA is influenced by diet, cellular breakdown and renal elimination hence hyperuricemia can occur as a consequence of increased production and/or decreased excretion of UA in the kidney6.
The relationship between MetS and hyperuricemia is suggested to be causal. Recent evidence indicated that the risk of developing MetS is higher with increased plasma levels of UA7 and patients with MetS have higher risk of hyperuricemia than those without8. Although the explanation for this relationship and the underling mechanisms are currently not clear, it is partly ascribed to insulin resistance as hyperinsulinemia reduces renal excretion of UA and sodium9. Previous findings have also indicated that the prevalence of insulin resistance is increased in obese individuals due to elevated production of leptin hormone10.
Both cross sectional and longitudinal studies11 demonstrated that high plasma UA increased the prevalence of MetS by affecting its individual components. While the component of MetS that is mostly influenced by hyperuricemia is variable in many populations, it is also not established whether the relationship between MetS and hyperuricemia is specific to sex as studies showed conflicting results12. Thus, more studies are needed to elucidate this relationship, and to establish whether hyperuricemia is indeed an important biomarker of MetS.
Some occupations are characterized by physical inactivity, sedentariness, long working hours and work-stress which promote unhealthy dietary patterns such as consumption of high fat diet, sugar-sweetened foods and drinks and excessive alcohol13. These foods and lifestyle factors play an important role in the development of hyperuricemia. A fructose-rich diet can raise UA production and induce the components of MetS through mechanisms independent of energy intake or weight gain14. Given the close association between MetS and hyperuricemia, it is important to explore this relationship among workers as only few studies have reported the effects of occupational factors on plasma UA. Oh, et al.,15 reported a significant association between shift work and hyperuricemia among Korean steelmaking male workers. In China, available evidence on the prevalence of hyperuricemia and its relationship with MetS focus on the general population16 or patients, with limited data on workers. Thus, the objective of this study was to examine the association between hyperuricemia and MetS and the components of MetS that are mostly influenced by hyperuricemia among university workers.
Subjects and methods
Subjects and research design
A total of 2273 adults (male, n=1198; female, n=1075) on annual medical examination at a University Hospital participated in the study. The workers were categorized into two occupation groups: administrators including workers involved in office work and academics involved in research and teaching or both. In our previous work, we found high prevalence of MetS and its components among the male workers compared to their female counterparts, which was attributed to gender and occupational differences17. In the present study, we further examined whether there was an association between MetS and hyperuricemia. The study was approved by the institution's Ethics committee and hospital management. The participants consented to the study. Study protocols were conducted in accordance with the recommendations outlined in Helsinki Declaration of 1975, revised 2000.
Data collection and laboratory analysis
The standard procedures for physical assessment weight (kg) and height (m), systolic and diastolic blood pressures (mmHg), and biochemical analysis have been described previously17. Briefly, weight and height of the participants were measured using the stadiometer (HW-700, Zhengzhou, China) and used to compute body mass index (BMI). Blood pressure was determined using standard sphygmomanometer (YE-665 A, Jiangsu, China). Overnight fasting blood samples were obtained by venipuncture and plasma separated by centrifugation (KDC-1044, Hangzhou, China) at 1000 ×g and 4°C for 10 minutes. Immediately, lipid profiles, glucose, uric acid, creatinine and urea were determined by enzymatic methods with an Automatic Biochemical Analyser (HF 0400, Shanghai, China) at the University Hospital laboratory.
Diagnosis
Metabolic syndrome
Metabolic syndrome was defined according to the Modified criteria of the National Cholesterol Education Program Adult Treatment Panel18. The criteria require the presence of at least three of the following components; central obesity, waist circumference >102 cm (males), >88 cm (females); systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg; fasting plasma glucose ≥ 5.6 mmol/L;dyslipidemia, triglycerides (TG)≥1.695 mmol/L and high density lipoprotein cholesterol( HDL) < 1.036 mmol/L (males), HDL< 1.295 mmol/L (females). Total cholesterol (TC) and HDL were used to calculate the atherosclerotic index (AI) as follows: AI= (TC mmol/L -HDL mmol/L) / HDL mmol/L.
Assessment of chronic kidney disease
The creatinine based equation that estimates glomerular filtration rate (GFR) was used to assess chronic kidney disease (CKD). This equation, in addition to plasma creatinine levels, takes into account individual differences in age, gender and race. Estimated GFR (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations19. The eGFR <60 ml/min/1.73 m2 was diagnosed as CKD. The CKD-EPI equation for estimatingGFR is as follows: eGFRCKD-EPI = 141 × min (Scr/k, 1)α × max (Scr/k, 1)−1.209 × 0.993Age × 1.018 (if female) × 1.159 (if black); where k is 0.7 for females and 0.9 for males, α is −0.329 for females and −0.411 for males, “min” indicates the lesser of Scr/k or 1, and “max” indicates the greater of Scr/k or 1.
Hyperuricemia
Using plasma UA levels, hyperuricemia was defined as ≥420 µmol/L in males and ≥ 360µ mol/L in females.
Statistical analysis
Data was analyzed using the Statistical Package for Social Scientists for Windows, 18 (SPSS, Inc. Chicago, USA). Data were expressed as means ± standard deviations, correlation coefficients (r), proportions (%), standardized regression coefficients (β), odds ratios and 95% confidence interval. Independent samples t-test and analysis of variance (ANOVA) were used to compare means, and Tukey's HSD test used for post hoc analysis. Associations were assessed by Chi-square (χ2) test, Pearson correlation, and conditional forward and backward binary logistic regression. P <0.05 was considered statistically significant.
Results
Age, body mass index and renal function tests of the study participants
Table 1 presents the age, body mass index (BMI) and renal function tests of the male (1198) and female (n=1075) study participants. As shown, age, BMI, plasma levels of uric acid (UA), creatinine, urea and estimated glomerular filtration rate (eGFRCKD-EPI) were significantly (P<0.01) higher in male than female workers. Overall prevalence of hyperuricemia was 10% with prevalence being significantly higher (χ2= 75.587, p=0.001) in male (15.2%) than female (4.1%) workers. CKD prevalence was 11.7% and was higher (χ2, 220.047, P<0.01) in males (21.7%) than females (0. 4%).
Table 1.
Age, body mass index and renal function tests of the study participants
| Characteristic | All (n=2273) | Male (n=1198) | Female (n=1075) | p |
| Age (years) | 42.63 ± 8.63 | 44.45± 8.01 | 40.45 ± 8.84 | 0.001 |
| Body mass index (kg/m2) | 22.95 ± 3.01 | 24.09 ± 2.92 | 21.67 ± 2.57 | 0.001 |
| Uric acid (µmol/L) | 306.61 ± 81.24 | 363.98 ± 68.71 | 252.81 ± 56.03 | 0.001 |
| Number (%) with high UAa | 228 (10) | 182 (15.2) | 44 (4.1) | 0.001 |
| Creatinine (µmol/L) | 67.05 ± 15.96 | 77.94 ± 12.72 | 54.98 ± 8.00 | 0.001 |
| Urea (mmol/L) | 4.53 ± 1.14 | 4.53 ± 1.14 | 4.88 ± 1.12 | 0.001 |
| eGFRCKD-EPI | 104.02 ± 40.95 | 75.52 ± 22.02 | 135.91 ± 32.95 | 0.001 |
| Number (%) with CKDb | 234 (11.7) | 230 (21.7) | 4 (0.4) | 0.001 |
Values are mean ± standard deviations; p<0.01 − statistically significant by independent samples t-test; high uric acid (UA) levels (≥ 420 µmol/L in males and ≥ 360µmol/L in females);
analysis by Chi (χ2) test statistic, (χ2=75.587); eGFR-estimated glomerular filtration rate by CKD-EPI-Chronic Kidney Disease Epidemiology Collaboration equation;
CKD − chronic kidney disease (eGFR <60 ml/min/1.73 m2) using CKD-EPI creatinine based equation for 1057 males and 941 females, χ2, 220.047).
Plasma uric acid concentrations in different levels of metabolic parameters
Plasma uric UA concentrations were significantly (P<0.01) higher in males and females with elevated systolic blood pressure (SBP) and diastolic blood pressure (DBP), TG, AI (TC-HDL/HDL ratio), fasting plasma glucose levels (FPG) and reduced HDL (Table 2).
Table 2.
Plasma uric acid concentrations in different levels of metabolic parameters
| Male | Female | |||||
| n | Uric acid (µmol/L) | p | n | Uric acid (µmol/L) | p | |
| SBP | ||||||
| ≥130 mmHg | 472 | 363.85 ± 71.23 | 0.001 | 156 | 249. 93 ± 54.22 | 0.001 |
| <130 mmHg | 698 | 347.18 ± 66.13 | 881 | 270.22 ± 63.17 | ||
| DBP | ||||||
| ≥85 mmHg | 581 | 364.23 ± 71.54 | 0.001 | 178 | 270.07 ± 62.41 | 0.001 |
| <85 mmHg | 589 | 343.71 ± 64.20 | 859 | 249.45 ± 54.07 | ||
| Triglycerides | ||||||
| ≥1.695mmol/L | 358 | 378.80 ± 73.05 | 0.001 | 105 | 292.11 ± 64.88 | 0.001 |
| ≥1.695 mmol/L | 814 | 343.19 ± 63.83 | 939 | 248.41 ± 53.20 | ||
| HDL | ||||||
| <1.036 mmol/L | 136 | 368.02 ± 75.47 | 0.011 | − | − | |
| ≥1.036 mmol/L | 1035 | 352.14 ± 67.59 | − | − | ||
| < 1.295 mmol/L | − | − | − | 170 | 269.18 ± 66.24 | 0.001 |
| > 1.295 mmol/L | − | − | − | 874 | 249.62 ± 53.27 | |
| TC-HDL/HDL | ||||||
| ≥2.64 | 663 | 369.09 ± 67.89 | 0.001 | 241 | 277.20 ± 61.19 | 0.001 |
| <2.64 | 508 | 334.26 ± 64.72 | 803 | 245.49 ± 52.23 | ||
| FPG | ||||||
| ≥ 5.6 mmol/L | 269 | 361.51 ± 72.76 | 0.042 | 70 | 278.81 ± 7.89 | 0.001 |
| <5.6 mmol/L | 900 | 351.79 ± 67.38 | 974 | 250.94 ± 54.27 | ||
Values are mean ± standard deviations; p<0.05 – statistically significant by independent samples t-test; SBP – systolic blood pressure; DBP – diastolic blood pressure; HDL – high density lipoprotein cholesterol; TC – total cholesterol; FPG – fasting plasma glucose.
Correlation between plasma UA concentrations and the metabolic parameters
Plasma UA increased with age in females and not in males (Table 3). UA associated positively (P<0.01) with BMI, SBP, DBP, TC, low density lipoprotein cholesterol (LDL), triglycerides (TG), atherosclerosis index, FPG (only females), and inversely with HDL in both sexes.
Table 3.
Correlation of plasma uric acid levels with metabolic parameters
| Male (n=1198) | Female (n=1075) | |
| Coefficient (r) | Coefficient (r) | |
| Age (y) | −0.008 | 0.082** |
| BMI (kg/m2) | 0.254** | 0.313** |
| SBP (mmHg) | 0.143** | 0.196** |
| DBP(mmHg) | 0.165** | 0.200** |
| TC (mmol/L) | 0.087** | 0.128** |
| LDL (mmol/L) | 0.102** | 0.189** |
| TG (mmol/L) | 0.280** | 0.259** |
| HDL (mmol/L) | −0.233** | −0.204** |
| TC-HDL/HDL | 0.293** | 0.293** |
| FPG (mmol/L) | 0.009 | 0.141** |
p<0.01 – statistically significant by Pearson correlations;
UA – uric acid; SBP – systolic blood pressure; DBP – diastolic blood pressure; TC – total cholesterol; TG – triglycerides; LDL– low density lipoprotein cholesterol; HDL– high density lipoprotein cholesterol; FPG – fasting plasma glucose.
Association of hyperuricemia with metabolic syndrome and its components
The participants were divided into two groups based on UA concentrations; hyperuricemic and normal UA group, and relationship with age, BMI, sex, renal function, MetS and each of its components examined. As shown in Table 4, hyperuricemia was 3 times significantly higher (OR, 2.938; 95% CI, 1.909–4.522, P<0.01) in males than females after adjustment for age, BMI and renal function. The MetS increased 3.7 times (OR, 3.682; 95% CI, 2.320–5.843, P<0.01), dyslipidemia, 2.5 times (OR, 2.512; 95% CI, 1.808–3.491, P<0.01) and hypertension, 1.4 times (OR, 1.421; 95% CI, 1.005–2.011, P<0.05) in hyperuricemic individuals compared to normal UA group after adjustment for age, sex and BMI. Further adjustments for kidney function increased MetS 4-fold (OR, 3.903, CI, 2.439–6.245, P<0.01) and dyslipidemia 2.5 times (OR. 2.501, 95% CI, 1.776–3.521, P<0.01). Hyperuricemia associated positively (P<0.05) with hyperglycemia (OR, 1.448; 95% CI, 1.020–2.054) only after adjustment for age and sex.
Table 4.
Association of hyperuricemia with metabolic syndrome and its components in all participants
| Parameter | Mode1 | Odds ratio | 95% CI | p |
| Age (y) | − | 1.025 | 1.009–1.042 | 0.003* |
| Body mass indexa | − | 1.283 | 1.212–1.358 | 0.001** |
| With CKD a | − | 0.598 | 0.405–0.885 | 0.010* |
| With CKDb | − | 0.687 | 0.445–1.060 | 0.090 |
| Sex(male)c | − | 2.938 | 1.909–4.522 | 0.001** |
| Metabolic syndromed | 1 | 4.259 | 2.841–6.384 | 0.001** |
| 2 | 3.682 | 2.320–5.843 | 0.001** | |
| 3 | 3.903 | 2.439–6.245 | 0.001** | |
| Dyslipidemiad | 1 | 3.211 | 2.396–4.303 | 0.001** |
| 2 | 2.512 | 1.808–3.491 | 0.001** | |
| 3 | 2.501 | 1.776–3.521 | 0.001** | |
| Hypertensiond | 1 | 1.812 | 1.330–2.469 | 0.001** |
| 2 | 1.421 | 1.005–2.011 | 0.047* | |
| 3 | 1.427 | 0.996–2.205 | 0.052 | |
| Hyperglycemiad | 1 | 1.448 | 1.020–2.054 | 0.038* |
| 2 | 1.387 | 0.938–2.051 | 0.101 | |
| 3 | 1.476 | 0.989–2.202 | 0.057 |
association with hyperuricemia (dependent variable) after adjustment for age;
association with hyperuricemia after adjustment for age and body mass index (BMI)
association with hyperuricemia after adjustment for age, BMI and kidney function;
dependent variable; Model 1– adjustment for age and sex; Model 2 – adjustment for age, sex and BMI; Model 3 – further adjustment for kidney function;
p<0.01,
p<0.05 statistically significant by binary logistic regression;
CI – confidence interval; CKD – chronic kidney disease.
Renal function tests by occupation type
The age and BMI were significantly (P<0.05) higher among administrators as compared to workers in academics for both gender (Table 5). Plasma UA and creatinine levels were higher (P<0.05) in male administrators compared to those in academics. However, there was no difference (P>0.05) in plasma UA and creatinine levels among female workers. Further, the prevalence of hyperuricemia in male administrators was significantly (P<0.05) higher (19%) than that of workers in academics (12.7%) although there was no difference in females.
Table 5.
Comparison of renal function tests of male and female workers by occupation
| Male (n=1198) | Female (n=1075) | |||||
| Administration (n=448) |
Academics (n=750) |
p | Administration (n=332) |
Academics (n=743) |
p | |
| Age (years) | 46.61±8.89 | 43.16±8.57 | 0.001 | 41.79±8.07 | 39.89±7.93 | 0.001 |
| Body mass index (kg/m2) |
24.34±3.26 | 23.95±2.71 | 0.042 | 21.99±2.54 | 21.54±2.58 | 0.017 |
| Uric acid | 360.75±71.44 | 349.89±66.73 | 0.009 | 255.72±55.27 | 251.26±56.59 | 0.234 |
| (µmol/L) | ||||||
| % with high UA† |
19.0 | 12.7 | 0.004 | 4.3 | 3.9 | 0.782 |
| Creatinine | 72.87±18.72 | 76.59±18.51 | 0.001 | 52.72±11.65 | 53.88±12.55 | 0.156 |
| (µmol/L) | ||||||
| Urea(mmol/L) | 4.94±1.17 | 4.85±1.09 | 0.184 | 4.27±1.05 | 4.11±1.06 | 0.028 |
| eGFRCKD-EPI | 76.69±22.13 | 74.58±22.09 | 0.125 | 138.82±36.93 | 135.63±34.35 | 0.188 |
| % with CKD‡ | 19.2 | 23.2 | 0.117 | 0 | 4 | 0.249 |
Values are mean ± standard deviations; p<0.05 – statistically significant by independent samples t-test; high uric acid (UA) levels (≥ 420 µmol/L in males and ≥ 360µmol/L in females);
analysis by Chi (χ2) test statistic, (Male, χ2= 8.526, female χ2 =0.077); eGFR – estimated glomerular filtration rate by CKD-EPI-Chronic Kidney Disease Epidemiology Collaboration equation;
CKD – chronic kidney disease (eGFR <60 ml/min/1.73 m2) using CKD-EPI creatinine based equation, males, χ2, 2.453 and female, χ2, 1.326.
Relationship between hyperuricemia and occupation in male workers
Male workers with CKD were excluded from analysis. The association between hyperuricemia and type of occupation was examined in 868 males. Hyperuricemia was 1.9-fold higher (P<0.05) in male administrators compared to their academic counterparts after adjusting for age and BMI (Table 6).
Table 6.
Association between hyperuricemia and occupation in male workers
| Model | Odds ratio | 95% confidence interval | P |
| 0 | 1.930 | 1.298–2.869 | 0.001 |
| 1 | 1.897 | 1.275–2.825 | 0.002 |
| 2 | 1.875 | 1.202–2.925 | 0.006 |
Odds ratios and 95% confidence intervals for workers in administration. Model 0 – unadjusted, Model 1 – adjustment for age; Model 2 – further adjustment for BMI; p<0.05 statistically significant by binary logistic regression. Individuals with chronic kidney disease were excluded from analysis.
Discussion
In the present study, hyperuricemia positively associated with MetS and the relationship was greater in males than females. Among MetS components, dyslipidemia showed greater associations with hyperuricemia after adjustments for age, sex, BMI and renal function. Moreover, administrative work was associated with a high prevalence of hyperuricemia among male workers but not in female workers. The high prevalence of hyperuricemia among male adults as compared with females (Table 1) is in consistence with reports on the general population in China16. This gender disparity could be attributed to age and hormonal differences as the male workers were much older than female workers who were largely pre-menopausal. High androgen levels in younger men promote renal uric acid (UA) re-absorption whereas estrogen in younger women promotes more efficient renal clearance of UA20. Thus, UA levels often increase after menopause in women. The disparity may also be attributed to sex differences in dietary habits and life styles.
The high prevalence of hyperuricemia may be related to increased production of UA from diet as high consumption of purine-rich foods such as meats and sea foods, sugar-sweetened food as well as alcohol consumption is common among the Chinese populations21. Villegas et al.,22 also reported a direct association between seafood consumption and hyperuricemia among middle-aged Chinese men. Hyperuricemia may also be due to high intake of fructose rich foods13. During fructose metabolism, ATP is consumed leading to accumulation of AMP which stimulates AMP deaminase, resulting in increased UA production.
The positive correlation of UA acid with metabolic parameters supports the role of diet in hyperuricemia. While BMI, blood pressure, lipid profiles and glucose increased with elevated UA in both sexes, HDL levels reduced (Table 2 and 3). This indicates that UA levels increase with body weight and can subsequently affect lipids, blood pressure and glucose. Obesity significantly affects UA metabolism23. Thus, among many other mechanisms, hyperuricemia is ascribed to increased production of leptin which is known to reduce the excretion of UA from the kidney. The increase in blood pressure could be attributed to endothelial dysfunction induced by hyperuricemia24. The increase in plasma glucose, TG, and reduced HDL may be linked to insulin resistance. In addition, hyperinsulinemia is closely related to high TG which is usually accompanied with reduced HDL levels.
In this study, after adjustment for confounding factors such as age, BMI and renal function, hyperuricemia was strongly associated with MetS (Table 4). This occurrence may be partly explained by the ability of UA to inhibit endothelial function as well as the effects from insulin resistance as explained earlier. Another possible mechanism by which hyperuricemia may be associated with MetS is through increased oxidative stress which we previously reported in these participants25. Further, among the components of MetS, dyslipidemia displayed a stronger association with hyperuricemia compared to hypertension and hyperglycemia. This observation concurs with findings from a previous longitudinal study17. Al-Meshaweh et al.,26 also reported that hyperuricemia was common in dyslipidemic patients. A plausible explanation may be related to dietary factors since hypertriglyceridemia and hyperuricemia are linked by a common denominator: a diet rich in fructose.
An interesting finding in this study was the high prevalence of hyperuricemia among male administrators as compared to those in academics even after adjustment for age and BMI, and excluding individuals with CKD in the analysis (Table 5 and 6). This may be explained by the nature of administrative work which is characterized by long periods of sitting and sedentariness27 as compared to other occupations in the university28. Prolonged sitting is associated with insulin resistance29, which, as explained earlier, causes reduced renal excretion of UA. The increased hyperuricemia among this occupation group might also be due to diet related factors as office-based workers may not have adequate time to eat or not able to access healthy foods30. Consequently, such workers may end up adopting lifestyles that promote development of hyperuricemia including consumption of convenient snacks that are high in fat, sugar-sweetened foods and drinks, and excessive alcohol14. Currently, there are few studies that determined the prevalence of hyperuricemia among workers in certain occupations. Oh et al.,15 reported a significant positive association between shift work and hyperuricemia.
The limitations of this study included the cross-sectional nature of the design that does not allow for inference on the causal relationships between plasma UA concentration and MetS over time. Thus, there is a need for a longitudinal study to further confirm this relationship. The potential effects of diet on plasma uric acid levels and plasma insulin concentrations were also not measured.
Conclusion
Elevated plasma levels of uric acid were positively associated with metabolic syndrome and its components among university workers. This relationship was stronger in male than female workers. Among the MetS components, dyslipidemia was closely associated with hyperuricemia as compared to hypertension and hyperglycemia. Hyperuricemia was also common in male administrators as compared to those in academics. These findings support that hyperuricemia is a risk factor for metabolic syndrome, especially among male workers. Thus, there is a need for workplace-based health interventions aimed at reducing hyperuricemia and dyslipidemia among workers.
Acknowledgement
This study was supported by the National Science and Technology Ministry of China. We are grateful to the physicians, Xue Fang, Liu Jin Feng, Jiang L Ping and Hua Wang of Jiangnan University Hospital for sample collection and analysis.
Conflicts of interest
Authors have no competing interests to declare.
References
- 1.Lee L, Sanders RA. Metabolic Syndrome. Pediatr Rev. 2012;33(10):459–468. doi: 10.1542/pir.33-10-459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Schultz AB, Edington DW. Analysis of the association between metabolic syndrome and disease in a workplace population over time. Value Health. 2010;13(2):258–264. doi: 10.1111/j.1524-4733.2009.00651.x. [DOI] [PubMed] [Google Scholar]
- 3.Johnson P, Turner L, Carter M, Kelly R, Ewell PJ. Metabolic syndrome prevalence and correlates in a worksite wellness program. Workplace Health Saf. 2015;63(6):245–252. doi: 10.1177/2165079915576920. [DOI] [PubMed] [Google Scholar]
- 4.Yadav D, Lee ES, Kim HM, Lee EY, Choi E, Chung CH. Hyperuricemia as a potential determinant of metabolic syndrome. J Lifestyle Med. 2013;3(2):98–106. [PMC free article] [PubMed] [Google Scholar]
- 5.Chen YY, Kao TW, Yang HF, Chou CW, Wu CJ, Lai CH. The association of uric acid with the risk of metabolic syndrome, arterial hypertension or diabetes in young subjects- An observational study. Clin Chim Acta. 2018;478:68–73. doi: 10.1016/j.cca.2017.12.038. PubMed. [DOI] [PubMed] [Google Scholar]
- 6.Oliveira EP, Burini RC. High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr. 2012;4:12. doi: 10.1186/1758-5996-4-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wei CY, Sun CC, Wei JCC, Tai HC, Sun CA, Chunge CF, et al. Association between hyperuricemia and metabolic syndrome: An epidemiological study of a labor force population in Taiwan. BioMed Research International. 2015:369179. doi: 10.1155/2015/369179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Vayá A, Rivera L, Hernández-Mijares A, Bautista D, Solá E, Romagnoli M, et al. Association of metabolic syndrome and its components with hyperuricemia in a Mediterranean population. Clin Hemorheol Microcirc. 2015;60(3):327–334. doi: 10.3233/CH-141887. [DOI] [PubMed] [Google Scholar]
- 9.Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013;25(2):210–216. doi: 10.1097/BOR.0b013e32835d951e. PubMed. [DOI] [PubMed] [Google Scholar]
- 10.Yadav A, Kataria MA, Saini V, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. 2013;417:80–84. doi: 10.1016/j.cca.2012.12.007. PubMed. [DOI] [PubMed] [Google Scholar]
- 11.Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine. 2012;41:450–457. doi: 10.1007/s12020-012-9629-8. PubMed. [DOI] [PubMed] [Google Scholar]
- 12.Huang S, Liu X, Li H, Xu W, Jia H. Sex difference in the association of serum uric acid with metabolic syndrome and its components: a cross-sectional study in a Chinese Yi population. Postgrad Med. 2017;129(8):828–833. doi: 10.1080/00325481.2017.1372034. PubMed. [DOI] [PubMed] [Google Scholar]
- 13.Thorndike AN. Workplace interventions to reduce obesity and cardiometabolic risk. Curr Cardiovasc Risk Rep. 2011;5(1):79–85. doi: 10.1007/s12170-010-0138-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Rho YH, Zhu Y, Choi HK. The epidemiology of uric acid and fructose. Semin Nephrol. 2011;31(5):410–419. doi: 10.1016/j.semnephrol.2011.08.004. PubMed. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Oh JS, Choi WJ, Lee MK, Han SW, Song SH, Yun JW. The association between shift work and hyperuricemia in steelmaking male workers. Ann Occup Environ Med. 2014;26:42. doi: 10.1186/s40557-014-0042-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Qiu L, Cheng X, Wu J, Liu JT, Xu T, Ding HT, et al. Prevalence of hyperuricemia and its related risk factors in healthy adults from Northern and Northeastern Chinese provinces. BMC Public Health. 2013;13:664. doi: 10.1186/1471-2458-13-664. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Cheserek MJ, Wu GR, Shen LY, Shi YH, Le GW. Disparities in the prevalenceof metabolic syndrome and its components among University employees by age, gender and occupation. J Clin Diag Res. 2014;8(2):65–69. doi: 10.7860/JCDR/2014/6515.4010. PubMed. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, author. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA. 2001;285:2486–2497. doi: 10.1001/jama.285.19.2486. PubMed. [DOI] [PubMed] [Google Scholar]
- 19.Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–612. doi: 10.7326/0003-4819-150-9-200905050-00006. PubMed. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Stöckl D, Döring A, Thorand B, Margit H, Petra B, Christa M. Reproductive factors and serum uric acid levels in females from the general population: The KORA F4 Study. PLoS ONE. 2012;7(3):e32668. doi: 10.1371/journal.pone.0032668. PubMed. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Xiong Z, Zhu C, Qian X, Qian X, Zhu J, Wu Z, et al. Serum uric acid is associated with dietary and lifestyle factors in elderly women in suburban Guangzhou in Guangdong province of South China. J Nutr Health Aging. 2013;17(1):30–34. doi: 10.1007/s12603-012-0076-2. [DOI] [PubMed] [Google Scholar]
- 22.Villegas R, Xiang YB, Elasy T, Xu WH, Cai H, Cai Q, et al. Purine-rich foods, protein intake, and the prevalence of hyperuricemia: the Shanghai Men's Health Study. Nutr Metab Cardiovasc Dis. 2012;22(5):409–416. doi: 10.1016/j.numecd.2010.07.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Matsuura F, Yamashita S, Nakamura T, Nishida M, Nozaki S, Funahashi T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998;47(8):929–933. doi: 10.1016/s0026-0495(98)90346-8. PubMed. [DOI] [PubMed] [Google Scholar]
- 24.Ho WJ, Tsai WP, Yu KH, Tsay PK, Wang CL, Hsu TS, et al. Association between endothelial dysfunction and hyperuricemia. Rheumatology. 2010;49:1929–1934. doi: 10.1093/rheumatology/keq184. PubMed. [DOI] [PubMed] [Google Scholar]
- 25.Cheserek MJ, Wu GR, Ntazinda A, Shi YH, Shen L, Ye, Le GW. Association between thyroid hormones, lipids and oxidative stress markers in subclinical hypothyroidism. J Med Biochem. 2014;33:1–9. doi: 10.2478/jomb-2014-0044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Al-Meshaweh AF, Jafar Y, Asem M, Akanji AO. Determinants of blood uric acid levels in a dyslipidemic Arab population. Med Princ Pract. 2012;21:209–216. doi: 10.1159/000333483. PubMed. [DOI] [PubMed] [Google Scholar]
- 27.Fountaine CJ, Piacentini M, Liguori GA. Occupational Sitting and Physical Activity Among University Employees. Int J Exerc Sci. 2014;7(4):295–301. doi: 10.70252/XARY1716. PubMed. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Waters CN, Ling EP, Chu AHY, Ng SHX, Chia A, Lim YW, et al. Assessing and understanding sedentary behaviour in office-based working adults: a mixed-method approach. BMC Public Health. 2016;16:360. doi: 10.1186/s12889-016-3023-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Dunstan DW, Kingwell BA, Larsen R, Healy GN, Cerin E, Hamilton MT, et al. Breaking up prolonged sitting reduces postprandial glucose and insulin responses. Diabetes Care. 2012;35(5):976–983. doi: 10.2337/dc11-1931. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Blackford K, Jancey J, Howat P, Ledger M, Lee AH. Office-based physical activity and nutrition intervention: barriers, enablers, and preferred strategies for workplace obesity prevention, Perth, Western Australia. Prev Chronic Dis. 2013;10:E154. doi: 10.5888/pcd10.130029. [DOI] [PMC free article] [PubMed] [Google Scholar]